EPA:ALTHE • FR0010120402
The current stock price of ALTHE.PA is 0.63 EUR. In the past month the price decreased by -17.53%. In the past year, price increased by 215.18%.
ChartMill assigns a technical rating of 3 / 10 to ALTHE.PA. When comparing the yearly performance of all stocks, ALTHE.PA is one of the better performing stocks in the market, outperforming 98.5% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to ALTHE.PA. Both the profitability and financial health of ALTHE.PA have multiple concerns.
Over the last trailing twelve months ALTHE.PA reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS decreased by -16.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -45.47% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 16.09 | 108.279B | ||
| 2M6 | MEDTRONIC PLC | 15.91 | 107.061B | ||
| SHL | SIEMENS HEALTHINEERS AG | 15.7 | 46.868B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 17.48 | 25.344B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 17.28 | 25.315B | ||
| BIM | BIOMERIEUX | 19.08 | 11.209B | ||
| DIA | DIASORIN SPA | 17.12 | 3.929B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.3 | 3.599B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.2 | 2.372B | ||
| 1AFX | CARL ZEISS MEDITEC AG - BR | 10.94 | 2.309B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France and currently employs 33 full-time employees. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
THERACLION
244, avenue Pierre Brossolette
Malakoff ILE-DE-FRANCE FR
Employees: 32
Phone: 33155489070
Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France and currently employs 33 full-time employees. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
The current stock price of ALTHE.PA is 0.63 EUR.
ALTHE.PA does not pay a dividend.
ALTHE.PA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALTHE.PA.
THERACLION (ALTHE.PA) currently has 32 employees.
You can find the ownership structure of THERACLION (ALTHE.PA) on the Ownership tab.